The WHO suggestions encourage the adoption of these technologies, provided they may be validated to show equivalent or superior general performance in comparison with common techniques. Manufacturers looking to put into practice these techniques should supply sturdy validation info to show their equivalence to pharmacopoeial strategies. The WHO also waiting for link from Forum Profiles (6)